"Mainz Biomed partners with Quest for colorectal cancer screening test" was originally created and published by Medical ...

Mainz Biomed has announced a partnership with Quest Diagnostics ... The test leverages polymerase chain reaction (PCR) technology to detect cancerous DNA in stool samples and is poised to enhance ...

Mainz Biomed’s stool-based ColoAlert test is designed to detect colorectal ... “We are excited by the opportunity to work with Quest Diagnostics,” commented Guido Baechler, Chief Executive ...

Patients with inflammatory bowel disease (IBD) reported mostly favorable responses with the use of mail-order kits for stool ...

Mainz Biomed’s stool-based ColoAlert test is designed to detect colorectal cancer tumor DNA to aid in identifying colorectal cancer in early stages. Through polymerase chain reaction (PCR) technology, ...